1st Counsel – Lifestyle
Author:
Oricell Therapeutics Co., Ltd.
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
April 9, 2026